Navigation Links
Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication
Date:12/29/2010

For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase.

Patients should discuss any concerns about their health and medical care with their doctor.

Patients should let their doctors know if they have or ever had any of the following:

• Tuberculosis (TB) or have been near someone who has TB. Your doctor will check you for TB with a skin test. If you have latent (inactive) TB, you will begin TB treatment before you start REMICADE®.

• Lived in a region where certain fungal infections like histoplasmosis or coccidioidomycosis are common.

• Infections that keep coming back, have diabetes or an immune system problem.

• Any type of cancer or a risk factor for developing cancer, for example, chronic obstructive pulmonary disease (COPD) or had phototherapy for psoriasis.

• Heart failure or any heart condition. Many people with heart failure should not take REMICADE®.

• Hepatitis B virus (HBV) infection or think you may be a carrier of HBV.

• Nervous system disorders (like multiple sclerosis or Guillain-Barre syndrome).

Also tell your doctor about any medications you are taking, including vaccines or Kineret (anakinra), and if you are pregnant, plan to become pregnant or are nursing. Adults and children should not receive a live vaccine while taking REMICADE®.

The following serious (sometimes fatal) side effects have been reported in people taking REMICADE.

Patients should tell their doctors right away if you have any of the signs listed below:

• Infections (like TB, blood infections, pneumonia)—fever, tiredness, cough, flu, or warm, red or painful skin or any open sores. REMICADE® can make you more likely to get an infection or make any infection that you have worse.

• Lymphoma, or any other cancers in adults and children.
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
2. Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotechs New Psoriasis Agent Stelara (ustekinumab) is High
3. Centocor Ortho Biotech Inc. Submits Application to FDA Seeking to Expand SIMPONI® Label to Include Inhibition of Structural Damage in Treatment of Psoriatic Arthritis
4. Centocor Ortho Biotech Inc. Announces NDA Submission for Abiraterone Acetate for the Treatment of Metastatic Advanced Prostate Cancer
5. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
6. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
7. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
8. Clinical Data Presented on OrthoGlide(R) Medial Knee Implant
9. ORTHO EVRA(R) Prescribing Information Updated
10. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
11. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Calif. , May 6, 2015  Genomic Health, ... Kim Popovits , Chairman of the Board, Chief Executive ... America Merrill Lynch 2015 Healthcare Conference in ... 3:40 p.m. Pacific Time (PT). To access ... go to the  Investor Relations  section of the company,s ...
(Date:5/6/2015)... 6, 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... today that it will host a conference call and ... for the period ended March 31, 2015 and to ... its clinical program for aramchol. Conference ...
(Date:5/6/2015)... May 6, 2015 Neuralstem, Inc. (NYSE MKT: ... to develop small molecule and cell therapy treatments for ... Jonathan Lloyd Jones to the position of Chief ... Mr. Lloyd Jones brings to the ... business development experience.   Most recently, Mr. Lloyd Jones ...
Breaking Medicine Technology:Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 2Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 3Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4
... Novel Biomarkers Displaying 90% Sensitivity in Breast ... ... announced today the,discovery and validation of the most frequent DNA alterations detected ... appeared in PLoS ONE. The study entitled, "Identification of,Novel High-Frequency DNA Methylation ...
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), an Atlanta-based ... has retained Financial,Relations Board (FRB), as its Investor ... HIV-1/AIDS vaccine human trial results need to be,conveyed ... AIDS,pandemic," stated Kathy Waller, co-president of FRB., ...
Cached Medicine Technology:Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers 2GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 2GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 3GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 4
(Date:5/6/2015)... (PRWEB) May 06, 2015 Established by ... wellness for the estimated 46 million Americans who suffer ... upon monthly medications to alleviate their symptoms. Medicationdiscountcard.com is ... to save patients money on the costs of these ... are used to treat the pain and inflammation in ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The American ... nomination period for its prestigious Integrated Water Resources Management ... IWRM approach to water resources projects. , An IWRM approach ... our establishment in 1964. In 2014, 12 projects were nominated ... IMPACT magazine features not only the 2014 AWRA IWRM Award ...
(Date:5/6/2015)... Wethersfield, Conn. (PRWEB) May 06, 2015 ... company in Wethersfield, Conn., has hired healthcare executive ... vice president. Olson will lead Qualidigm’s growing ... further Qualidigm’s mission to improve the quality, safety, ... Olson comes to Qualidigm from Interim HealthCare of ...
(Date:5/6/2015)... 2015 Novodiax announced today that ... of Innovations with Ed Begley Jr., airing via ... times TBA. , This segment will explore Novodiax, ... diagnostics. Audiences will learn about Novodiax’s polymer detection ... behind the scenes to investigate how, based on ...
(Date:5/6/2015)... The Center for Innovative Technology (CIT) announced ... e-Kare, Inc. of Fairfax, VA, a digital health company ... wounds. , Chronic wounds include pressure, venous, and diabetic ... over 6.5 million U.S. patients, costing over $25 billion. ... the Children’s National Medical Center (CNMC), e-Kare ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:Novodiax to Be Featured in Upcoming Episode of Innovations TV Series 2Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3
... Clearly Contacts, the ... BC Business Magazines, Top 100 Public Companies list for the fifth consecutive year. Clearly ... with revenue of $119 million for fiscal 2008. , ... Vancouver, British Columbia (Vocus) June 30, 2009 -- Clearly Contacts ...
... ... editor-in-chief of Orthopaedic Knowledge Online, William A. Grana, MD, MPH, will be inducted into ... July 11th during its Annual Meeting in Keystone, Colorado. , ... Keystone, CO (Vocus) June 30, 2009 ...
... Limited (Chiltern), a global clinical research organization (CRO) announced that ... , , Dr. Attila Lorinczi will lead ... Medical Society and the Society of Hungarian Urologists. Dr. Lorinczi ... years, most recently as a clinical operations manager. , ...
... Oxford University Press is proud to present the ... AMA Manual of Style, the "bible" ... involved in medical or scientific publishing. Because scientific, medical, and ... a new treatment hinges on how well the evidence to ...
... , MINNEAPOLIS, June 29 HealthFitness Corporation (NYSE ... employee health and productivity management solutions, announced today that the ... the close of market on June 26, 2009, when Russell ... indexes. , , About HealthFitness , ...
... in doctor,s office, for example, at risk, study shows , ... blood pressure that can happen in a doctor,s office, or ... sustained high blood pressure, a new study finds. , Researchers ... In white-coat hypertension, a patient,s blood pressure is high while ...
Cached Medicine News:Health News:Clearly Contacts Named to BC Business Magazine Top 100 Public Companies List 2Health News:Teacher and Profession Leader, William A. Grana, MD, MPH, Inducted into Sports Medicine Hall of Fame 2Health News:Teacher and Profession Leader, William A. Grana, MD, MPH, Inducted into Sports Medicine Hall of Fame 3Health News:Chiltern Opens Office in Budapest, Hungary 2Health News:AMA Manual of Style, the 'Bible' for Medical and Scientific Publishing, Gains Online Presence 2Health News:HealthFitness Added to the Russell Microcap Index 2Health News:Sporadic Spikes in Blood Pressure Hike Chances of Hypertension 2
Duckbill type, sharp. 3 mm x 8 mm curved blade. Octagonal handle....
10 mm wide tip....
9 mm wide tip. 35 mm from angle to tip....
Designated most popular model or size. 4 mm wide tip....
Medicine Products: